Pharmaceutical compounding (503B) is compounding pharmacies with outsourcing facilities that may manufacture large batches with or without prescriptions to be sold to healthcare facilities for office use only. 503B compounding pharmacies that provide patient-specific medications are held to higher regulatory standards. These facilities must comply with current good manufacturing practices (CGMP).
Community Discussions
Community Discussions
May 18, 2024
May 17, 2024
May 17, 2024
May 16, 2024
Manufacturing Operations
May 14, 2024
May 13, 2024
May 13, 2024